Research programme: HIV vaccine (multivalent) - AlphaVaxAlternative Names: HIV (multivalent) - AlphaVax; Multi-gene HIV alphavaccine product - AlphaVax
Latest Information Update: 16 Jul 2016
At a glance
- Originator AlphaVax
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-1-infections in USA
- 31 Dec 2009 Preclinical trials in HIV-1 infections in USA (unspecified route)